Recombinant human erythropoietin (Uni-Bio Science Group)

N/A

Report date: 2024/03/22 16:27:14

Base Information

Drug NameRecombinant human erythropoietin (Uni-Bio Science Group)
Drug Alias NamerhEPO-Fc (Uni-Bio Science Group)
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant coagulation factor
Mechanisms of ActionErythropoiesis stimulantsErythropoietin receptor agonists
TargetsErythropoietin receptor
Therapy Area/IndicationsInfant, Newborn, DiseasesAnemia, NeonatalAnemia +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUni-Bio Science Group
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUni-Bio Science GroupNational Center For Research Resources
Active IndicationsN/A
Inactive IndicationsInfant, Newborn, DiseasesAnemia, NeonatalAnemia +[4] 

Other Information

ATC CodeN/A
Related LinksN/A